Stay updated on Nivolumab and Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Ipilimumab in Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T00:41:50.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with a revision update from v2.16.0 to v2.16.2.
    Difference
    0.9%
    Check dated 2025-06-05T16:12:54.000Z thumbnail image
  3. Check
    23 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-08T06:48:55.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The page has undergone significant content removal, particularly regarding the details of a clinical study on melanoma, including its purpose, design, and inclusion/exclusion criteria. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    6%
    Check dated 2025-04-16T14:39:05.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T09:40:55.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:26:52.000Z thumbnail image

Stay in the know with updates to Nivolumab and Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab in Melanoma Clinical Trial page.